Vedere Bio
0 followers
?
Vedere Bio II, Inc.? is a company developing next generation ocular gene therapies designed for vision restoration and preservation for patients with vision loss due to photoreceptor death.
Industries
Headquarters
Employees
Links
Org chart
Mike Murtagh
SVP, Regulatory Affairs
Martina Schinke
VP, Program Leader
Daniel Zimmer
Senior Director, Program Lead
Ellen Zyrkowski
Associate Director, HR & Communications
Soraya Bekkali, MD
Non Executive Director
Xiaozhi Ren (任小峙) Ph.D.
Director, CMC, Cell Line and Process Development
Karen Guerin
Senior Director, Discovery Research
